» Articles » PMID: 35851375

Engineering Circular RNA for Enhanced Protein Production

Overview
Journal Nat Biotechnol
Specialty Biotechnology
Date 2022 Jul 19
PMID 35851375
Authors
Affiliations
Soon will be listed here.
Abstract

Circular RNAs (circRNAs) are stable and prevalent RNAs in eukaryotic cells that arise from back-splicing. Synthetic circRNAs and some endogenous circRNAs can encode proteins, raising the promise of circRNA as a platform for gene expression. In this study, we developed a systematic approach for rapid assembly and testing of features that affect protein production from synthetic circRNAs. To maximize circRNA translation, we optimized five elements: vector topology, 5' and 3' untranslated regions, internal ribosome entry sites and synthetic aptamers recruiting translation initiation machinery. Together, these design principles improve circRNA protein yields by several hundred-fold, provide increased translation over messenger RNA in vitro, provide more durable translation in vivo and are generalizable across multiple transgenes.

Citing Articles

A versatile toolbox for determining IRES activity in cells and embryonic tissues.

Koch P, Zhang Z, Genuth N, Susanto T, Haimann M, Khmelinskaia A EMBO J. 2025; .

PMID: 40082722 DOI: 10.1038/s44318-025-00404-5.


Characterization of group I introns in generating circular RNAs as vaccines.

Liao K, Eshaghi M, Hong Z, Saw T, Lim J, Han J Nucleic Acids Res. 2025; 53(4).

PMID: 40036878 PMC: 11879131. DOI: 10.1093/nar/gkaf089.


Coding circular RNA in human cancer.

Lin Y, Wang Y, Li L, Zhang K Genes Dis. 2025; 12(3):101347.

PMID: 40034125 PMC: 11875173. DOI: 10.1016/j.gendis.2024.101347.


CircRNAs in Colorectal Cancer: Unveiling Their Roles and Exploring Therapeutic Potential.

Ding Y, Song X, Chen J Biochem Genet. 2025; .

PMID: 40029586 DOI: 10.1007/s10528-025-11068-5.


Recent advances and perspectives on the development of circular RNA cancer vaccines.

Gong Z, Hu W, Zhou C, Guo J, Yang L, Wang B NPJ Vaccines. 2025; 10(1):41.

PMID: 40025038 PMC: 11873252. DOI: 10.1038/s41541-025-01097-x.


References
1.
Baden L, El Sahly H, Essink B, Kotloff K, Frey S, Novak R . Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N Engl J Med. 2020; 384(5):403-416. PMC: 7787219. DOI: 10.1056/NEJMoa2035389. View

2.
Walsh E, Frenck Jr R, Falsey A, Kitchin N, Absalon J, Gurtman A . Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates. N Engl J Med. 2020; 383(25):2439-2450. PMC: 7583697. DOI: 10.1056/NEJMoa2027906. View

3.
Obi P, Chen Y . The design and synthesis of circular RNAs. Methods. 2021; 196:85-103. PMC: 8670866. DOI: 10.1016/j.ymeth.2021.02.020. View

4.
Chen Y, Kim M, Chen X, Batista P, Aoyama S, Wilusz J . Sensing Self and Foreign Circular RNAs by Intron Identity. Mol Cell. 2017; 67(2):228-238.e5. PMC: 5610545. DOI: 10.1016/j.molcel.2017.05.022. View

5.
Wesselhoeft R, Kowalski P, Anderson D . Engineering circular RNA for potent and stable translation in eukaryotic cells. Nat Commun. 2018; 9(1):2629. PMC: 6035260. DOI: 10.1038/s41467-018-05096-6. View